Drugs / Growth Hormone Releasing Hormone
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 23 trials | ||||||
| Phase 2 | NCT01410799 | May → Jun 2011 | pituitary deficiency | University of Pennsylvania | Terminated | No outcome recorded Stop: Business |
| Phase 2 | NCT00807365 | Dec 2007 → Apr 2010 | — | Johns Hopkins University | Terminated | No outcome recorded |
| Phase 2 | NCT00791843 | Mar 2004 → Aug 2011 | congestive heart failure | University of Pennsylvania | Completed | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 1 | NCT02271282 Background | Dec 2014 → May 2016 | — | Mayo Clinic | Completed | No outcome recorded |
| Phase 3 | NCT00448747 Comparator | Jun 2007 → Jul 2011 | pituitary deficiency | AEterna Zentaris | Completed | No outcome recorded |
| Phase 4 | NCT00720902 Comparator | Feb 2007 → Mar 2010 | pituitary deficiency | Columbia University | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | growth hormone releasing hormone | “A single combined IV injection of growth hormone releasing hormone (GHRH)/ghrelin (both doses 0.3mcg/kg) will be given on the overnight visit.” NCT02271282 ↗ |
| Known as | GHRH | “PP1- The purpose of this study is to determine whether giving more of the hormone produced by everyone called growth hormone releasing hormone (GHRH) can improve heart function...” NCT00791843 ↗4“naturally occurring hormone, called Growth Hormone Releasing Hormone (GHRH)” NCT01410799 ↗ |
| Action | Activate | “GHRH stimulates Growth Hormone (GH).” NCT00791843 ↗ |
| Route | Intravenous | “L-ARG+GHRH (iv bolus)” NCT00448747 ↗ |